Literature DB >> 8570778

Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia.

M J Cuesta1, V Peralta.   

Abstract

Recent factor-analytic studies have derived several trisyndromic models for schizophrenia, all based on the positive, negative, and disorganization syndromes. The goal of this study was to examine cognitive disorders in these three schizophrenic syndromes. The study group was composed of 40 schizophrenic patients consecutively admitted to the hospital due to a recrudescence of their symptomatology. They were selected on the basis of a semistructured interview, diagnosed with DSM-III-R criteria, and evaluated with scales for positive and negative symptoms. Their cognitive disorders were assessed with a battery of neuropsychological tests. The schizophrenic syndromes were weakly associated with cognitive performance through direct correlations and after correction for confounding variables. The disorganization and negative syndromes were more strongly associated with cognitive disturbances than was the positive syndrome, and both were associated with disturbances of visual-motor processes. Moreover, the disorganization syndrome was associated with disturbances in language and verbal memory and in time-controlled performance.

Entities:  

Mesh:

Year:  1995        PMID: 8570778     DOI: 10.1016/0165-1781(95)02712-6

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  27 in total

1.  Disorganization and reality distortion in schizophrenia: a meta-analysis of the relationship between positive symptoms and neurocognitive deficits.

Authors:  Joseph Ventura; April D Thames; Rachel C Wood; Lisa H Guzik; Gerhard S Hellemann
Journal:  Schizophr Res       Date:  2010-06-25       Impact factor: 4.939

Review 2.  Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

3.  Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia.

Authors:  Buranee Kanchanatawan; Solaphat Hemrungrojn; Supaksorn Thika; Sunee Sirivichayakul; Kiat Ruxrungtham; André F Carvalho; Michel Geffard; George Anderson; Michael Maes
Journal:  Mol Neurobiol       Date:  2017-09-05       Impact factor: 5.590

4.  Memantine Effects on Electroencephalographic Measures of Putative Excitatory/Inhibitory Balance in Schizophrenia.

Authors:  Juan L Molina; Bradley Voytek; Michael L Thomas; Yash B Joshi; Savita G Bhakta; Jo A Talledo; Neal R Swerdlow; Gregory A Light
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-02-22

5.  Cognitive functioning and negative symptoms in first episode schizophrenia: different patterns of correlates.

Authors:  José Manuel Rodríguez-Sánchez; Benedicto Crespo-Facorro; César González-Blanch; Rocío Pérez-Iglesias; Mario Alvarez-Jiménez; Obdulia Martínez; José Luis Vázquez-Barquero
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

6.  Reduced depth inversion illusions in schizophrenia are state-specific and occur for multiple object types and viewing conditions.

Authors:  Brian P Keane; Steven M Silverstein; Yushi Wang; Thomas V Papathomas
Journal:  J Abnorm Psychol       Date:  2013-05

7.  Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis.

Authors:  Joseph Ventura; Gerhard S Hellemann; April D Thames; Vanessa Koellner; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2009-07-22       Impact factor: 4.939

8.  Course of intelligence deficits in early onset, first episode schizophrenia: a controlled, 5-year longitudinal study.

Authors:  Jens Richardt Moellegaard Jepsen; Birgitte Fagerlund; Anne Katrine Pagsberg; Anne Marie R Christensen; Rikke W Hilker; Merete Nordentoft; Erik L Mortensen
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-09-10       Impact factor: 4.785

Review 9.  Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms.

Authors:  Michael A Cirillo; Larry J Seidman
Journal:  Neuropsychol Rev       Date:  2003-06       Impact factor: 7.444

10.  Source monitoring improvement in patients with schizophrenia receiving antipsychotic medications.

Authors:  Richard S E Keefe; Margaret P Poe; Joseph P McEvoy; Adam Vaughan
Journal:  Psychopharmacology (Berl)       Date:  2003-05-21       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.